(GIB) CGI - Ratings and Ratios
IT Consulting, Integration, Software Solutions, Managed Services, Cybersecurity
GIB EPS (Earnings per Share)
GIB Revenue
Description: GIB CGI October 16, 2025
CGI Inc. (NYSE:GIB) is a global provider of information technology and business process services, offering a broad portfolio that spans strategic IT consulting, systems integration, software development, application modernization, DevOps, digital and intelligent automation, cybersecurity, advanced analytics, and managed infrastructure. The firm serves a diversified client base across government, financial services, health care, utilities, communications, energy, manufacturing, insurance, life sciences, retail, and logistics sectors, operating in North America, Europe, Asia-Pacific and other international markets.
Key recent metrics show CGI generated approximately $14.5 billion in revenue for FY 2023, reflecting a modest 5% year-over-year increase driven by higher demand for cloud migration and cybersecurity services. The company posted an operating margin of roughly 10.5% and free cash flow of $1.2 billion, supporting a backlog of about $10 billion that underpins near-term revenue visibility. Macro-level drivers include accelerating digital transformation spending (global IT services market expected to grow ~6% CAGR through 2028) and sustained government IT budgets, which historically provide a recession-resilient revenue stream for firms like CGI.
For a deeper quantitative assessment of CGI’s valuation relative to peers, the ValueRay platform offers a data-driven dashboard worth exploring.
GIB Stock Overview
| Market Cap in USD | 19,485m | 
| Sub-Industry | IT Consulting & Other Services | 
| IPO / Inception | 1998-10-07 | 
GIB Stock Ratings
| Growth Rating | -9.80% | 
| Fundamental | 75.7% | 
| Dividend Rating | 28.4% | 
| Return 12m vs S&P 500 | -34.6% | 
| Analyst Rating | 3.94 of 5 | 
GIB Dividends
| Dividend Yield 12m | 0.49% | 
| Yield on Cost 5y | 0.71% | 
| Annual Growth 5y | 0.00% | 
| Payout Consistency | 100.0% | 
| Payout Ratio | 5.5% | 
GIB Growth Ratios
| Growth Correlation 3m | -88% | 
| Growth Correlation 12m | -85.2% | 
| Growth Correlation 5y | 75% | 
| CAGR 5y | 3.96% | 
| CAGR/Max DD 3y (Calmar Ratio) | 0.13 | 
| CAGR/Mean DD 3y (Pain Ratio) | 0.49 | 
| Sharpe Ratio 12m | 0.02 | 
| Alpha | -35.12 | 
| Beta | 0.540 | 
| Volatility | 21.30% | 
| Current Volume | 495.3k | 
| Average Volume 20d | 287.9k | 
| Stop Loss | 84.4 (-3.1%) | 
| Signal | 0.48 | 
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.71b TTM) > 0 and > 6% of Revenue (6% = 931.7m TTM) | 
| FCFTA 0.10 (>2.0%) and ΔFCFTA -2.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) | 
| NWC/Revenue 7.28% (prev 4.32%; Δ 2.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) | 
| CFO/TA 0.11 (>3.0%) and CFO 2.20b > Net Income 1.71b (YES >=105%, WARN >=100%) | 
| Net Debt (3.11b) to EBITDA (3.00b) ratio: 1.04 <= 3.0 (WARN <= 3.5) | 
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) | 
| Outstanding Shares last Quarter (224.4m) change vs 12m ago -2.68% (target <= -2.0% for YES) | 
| Gross Margin 16.65% (prev 16.29%; Δ 0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) | 
| Asset Turnover 88.77% (prev 91.91%; Δ -3.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) | 
| Interest Coverage Ratio 24.07 (EBITDA TTM 3.00b / Interest Expense TTM 100.3m) >= 6 (WARN >= 3) | 
Altman Z'' 3.75
| (A) 0.06 = (Total Current Assets 5.25b - Total Current Liabilities 4.12b) / Total Assets 19.19b | 
| (B) 0.39 = Retained Earnings (Balance) 7.55b / Total Assets 19.19b | 
| (C) 0.14 = EBIT TTM 2.41b / Avg Total Assets 17.49b | 
| (D) 1.10 = Book Value of Equity 9.87b / Total Liabilities 8.98b | 
| Total Rating: 3.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) | 
ValueRay F-Score (Strict, 0-100) 75.66
| 1. Piotroski 6.0pt = 1.0 | 
| 2. FCF Yield 6.36% = 3.18 | 
| 3. FCF Margin 12.46% = 3.12 | 
| 4. Debt/Equity 0.42 = 2.42 | 
| 5. Debt/Ebitda 1.04 = 1.71 | 
| 6. ROIC - WACC (= 6.65)% = 8.31 | 
| 7. RoE 17.24% = 1.44 | 
| 8. Rev. Trend 86.08% = 6.46 | 
| 9. EPS Trend -39.26% = -1.96 | 
What is the price of GIB shares?
Over the past week, the price has changed by -1.33%, over one month by -2.06%, over three months by -10.17% and over the past year by -22.41%.
Is CGI a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GIB is around 73.12 USD . This means that GIB is currently overvalued and has a potential downside of -16.05%.
Is GIB a buy, sell or hold?
- Strong Buy: 4
- Buy: 9
- Hold: 1
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the GIB price?
| Issuer | Target | Up/Down from current | 
|---|---|---|
| Wallstreet Target Price | 102.4 | 17.5% | 
| Analysts Target Price | 102.4 | 17.5% | 
| ValueRay Target Price | 80.4 | -7.6% | 
GIB Fundamental Data Overview October 27, 2025
P/E Trailing = 16.1704
P/E Forward = 13.947
P/S = 1.2523
P/B = 2.7442
P/EG = 1.5647
Beta = 0.54
Revenue TTM = 15.53b CAD
EBIT TTM = 2.41b CAD
EBITDA TTM = 3.00b CAD
Long Term Debt = 3.57b CAD (from longTermDebt, last quarter)
Short Term Debt = 167.5m CAD (from shortTermDebt, last quarter)
Debt = 4.24b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.11b CAD (from netDebt column, last quarter)
Enterprise Value = 30.41b CAD (27.30b + Debt 4.24b - CCE 1.13b)
Interest Coverage Ratio = 24.07 (Ebit TTM 2.41b / Interest Expense TTM 100.3m)
FCF Yield = 6.36% (FCF TTM 1.94b / Enterprise Value 30.41b)
FCF Margin = 12.46% (FCF TTM 1.94b / Revenue TTM 15.53b)
Net Margin = 11.01% (Net Income TTM 1.71b / Revenue TTM 15.53b)
Gross Margin = 16.65% ((Revenue TTM 15.53b - Cost of Revenue TTM 12.94b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 16.41%)
Tobins Q-Ratio = 1.58 (Enterprise Value 30.41b / Total Assets 19.19b)
Interest Expense / Debt = 0.79% (Interest Expense 33.6m / Debt 4.24b)
Taxrate = 25.92% (143.0m / 551.6m)
NOPAT = 1.79b (EBIT 2.41b * (1 - 25.92%))
Current Ratio = 1.27 (Total Current Assets 5.25b / Total Current Liabilities 4.12b)
Debt / Equity = 0.42 (Debt 4.24b / totalStockholderEquity, last quarter 10.21b)
Debt / EBITDA = 1.04 (Net Debt 3.11b / EBITDA 3.00b)
Debt / FCF = 1.61 (Net Debt 3.11b / FCF TTM 1.94b)
Total Stockholder Equity = 9.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.91% (Net Income 1.71b / Total Assets 19.19b)
RoE = 17.24% (Net Income TTM 1.71b / Total Stockholder Equity 9.92b)
RoCE = 17.89% (EBIT 2.41b / Capital Employed (Equity 9.92b + L.T.Debt 3.57b))
RoIC = 13.65% (NOPAT 1.79b / Invested Capital 13.10b)
WACC = 7.00% (E(27.30b)/V(31.54b) * Re(8.0%) + D(4.24b)/V(31.54b) * Rd(0.79%) * (1-Tc(0.26)))
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.06%
[DCF Debug] Terminal Value 79.11% ; FCFE base≈1.93b ; Y1≈2.04b ; Y5≈2.43b
Fair Price DCF = 214.1 (DCF Value 42.57b / Shares Outstanding 198.8m; 5y FCF grow 6.55% → 3.0% )
EPS Correlation: -39.26 | EPS CAGR: -56.86% | SUE: -4.0 | # QB: 0
Revenue Correlation: 86.08 | Revenue CAGR: 9.13% | SUE: 0.05 | # QB: 0
Additional Sources for GIB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle